Diagnosis of invasive pulmonary aspergillosis by metagenomic next-generation sequencing: a case report
SUN Jie1 LIU Jian2 FENG Jihong2
1.Graduate School, Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China; 2.Department of Respiratory and Critical Care Medicine, the Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300143, China
Abstract：Invasive pulmonary aspergillosis is difficult to distinguish from other pulmonary infections in clinic, and is easy to be misdiagnosed or missed. This paper report, a case of invasive pulmonary aspergillosis diagnosed by macrogene second generation sequencing, to investigate the diagnostic value of metagenomic next-generation sequencing in patients with invasive pulmonary aspergillosis. The main clinical manifestations of the patient were high fever, cough, and sputum with blood, after admission, the initial diagnosis was “bacterial pneumonia”, Cefoperazone sodium sulbactam sodium, Meropenem were given successively, the effect is not good, the relevant examination did not obtain sufficient etiological evidence, the metagenomic next-generation sequencing technology and pathological examination were performed, and the results indicated pulmonary infection of aspergillus, the antibiotic was changed to Voriconazole, and the patient was discharged after treatment. The possibility of fungal infection should be considered in patients with pulmonary infection who are not well treated by conventional antibiotics, if the pathogenic bacteria cannot be identified by routine examination, the diagnostic value of metagenomic next-generation sequencing technology should be emphasized.
孙洁1 刘健2 封继宏2. 宏基因二代测序诊断侵袭性肺曲霉病1例报道[J]. 中国医药导报, 2023, 20(29): 177-181.
SUN Jie1 LIU Jian2 FENG Jihong2. Diagnosis of invasive pulmonary aspergillosis by metagenomic next-generation sequencing: a case report. 中国医药导报, 2023, 20(29): 177-181.
[1] Ergün M，Brüggemann RJM，Alanio A，et al. Aspergillus Test Profiles and Mortality in Critically Ill COVID-19 Patients [J]. J Clin Microbiol，2021，59（12）：e01229-21. [2] Donnelly JP，Chen SC，Kauffman CA，et al. Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium [J]. Clin Infect Dis，2020，71（6）：1367- 1376. [3] Tudesq JJ，Peyrony O，Lemiale V，et al. Invasive Pulmonary Aspergillosis in Nonimmunocompromised Hosts [J]. Semin Respir Crit Care Med，2019，40（4）：540-547. [4] 中华医学会重症医学分会.重症患者侵袭性真菌感染诊断与治疗指南（2007）[J].中华内科杂志，2007，46（11）：960-966. [5] Gu W，Miller S，Chiu CY. Clinical Metagenomic Next-Generation Sequencing for Pathogen Detection [J]. Annu Rev Pathol，2019，14：319-338. [6] Mudrakola HV，Tandon YK，Demartino E，et al. Autopsy study of fatal invasive pulmonary aspergillosis：Often undiagnosed premortem [J]. Respir Med ，2022，199：5. [7] Zarif A，Thomas A，Vayro A. Chronic Pulmonary Aspergillosis：A Brief Review [J]. Yale J Biol Med，2021，94（4）：673- 679. [8] Herbrecht R，Guffroy B，Danion F，et al. Validation by Real- life Data of the New Radiological Criteria of the Revised and Updated Consensus Definition for Invasive Fungal Diseases [J]. Clin Infect Dis，2020，71（10）：2773-2774. [9] Reizine F，Pinceaux K，Lederlin M，et al. Influenza- and COVID-19-Associated Pulmonary Aspergillosis：Are the Pictures Different? [J]. J Fungi（Basel），2021，7（5）：388. [10] Jhun BW，Jeon K，Eom JS，et al. Clinical characteristics and treatment outcomes of chronic pulmonary aspergillosis [J]. Med Mycol，2013，51（8）：811-817. [11] 高东田，刘利华，申爱华，等.侵袭性肺曲霉菌感染实验诊断新进展[J].检验医学，2021，36（4）：453-461. [12] Borman AM，Palmer MD，Fraser M，et al. COVID-19-Associated Invasive Aspergillosis：Data from the UK National Mycology Reference Laboratory [J]. J Clin Microbiol，2020， 59（1）：e02136-20. [13] Van De Veerdonk FL，Brüggemann RJM，Vos S，et al. COVID-19-associated Aspergillus tracheobronchitis：the interplay between viral tropism，host defence，and fungal invasion [J]. Lancet Respir Med，2021，9（7）：795-802. [14] Aubry A，Porcher R，Bottero J，et al. Occurrence and kinetics of false-positive Aspergillus galactomannan test results following treatment with beta-lactam antibiotics in patients with hematological disorders [J]. J Clin Microbiol，2006，44（2）：389-394. [15] Vergidis P，Walker RC，Kaul DR，et al. False-positive Aspergillus galactomannan assay in solid organ transplant recipients with histoplasmosis [J]. Transpl Infect Dis，2012， 14（2）：213-217. [16] Mori Y，Nagasaki Y，Kamezaki K，et al. High incidence of false-positive Aspergillus galactomannan test in multiple myeloma [J]. Am J Hematol，2010，85（6）：449-451. [17] 王月，刘子航，王雪珍，等.曲霉特异性IgG联合血清半乳甘露聚糖检测对慢性肺曲霉菌病的诊断价值[J].中国现代医生，2021，59（11）：13-16，20. [18] Herrera S，Husain S. Current State of the Diagnosis of Invasive Pulmonary Aspergillosis in Lung Transplantation [J]. Front Microbiol，2019，9：9. [19] Sahoo MK，Lefterova MI，Yamamoto F，et al. Detection of Cytomegalovirus Drug Resistance Mutations by Next-Generation Sequencing [J]. J Clin Microbiol，2013，51（11）：3700-3710. [20] Zhao Z，Song J，Yang C，et al. Prevalence of Fungal and Bacterial Co-Infection in Pulmonary Fungal Infections：A Metagenomic Next Generation Sequencing-Based Study [J]. Front Cell Infect Microbiol，2021，11：749905. [21] Winters B，Custer J，Galvagno SM，et al. Diagnostic errors in the intensive care unit：a systematic review of autopsy studies [J]. BMJ Qual Saf，2012，21（11）：894-902. [22] Wang J，Han Y，Feng J. Metagenomic next-generation sequencing for mixed pulmonary infection diagnosis [J]. BMC Pulm Med，2019，19（1）：252. [23] Chen Y，Feng W，Ye K，et al. Application of Metagenomic Next-Generation Sequencing in the Diagnosis of Pulmonary Infectious Pathogens From Bronchoalveolar Lavage Samples [J]. Front Cell Infect Microbiol，2021，11：541092. [24] Li Y，Sun B，Tang X，et al. Application of metagenomic next-generation sequencing for bronchoalveolar lavage diagnostics in critically ill patients [J]. Eur J Clin Microbiol Infect Dis，2020，39（2）：369-374. [25] 林少刚.宏基因二代测序对侵袭性肺曲霉菌病的诊断价值及其临床应用[D].福州：福建医科大学，2021. [26] Liu N，Kan J，Yu N，et al. Application of metagenomic next- generation sequencing technology for difficult lung lesions in patients with haematological diseases [J]. Transl Cancer Res，2020，9（9）：5245-5254. [27] Miao Q，Ma YY，Wang QQ，et al. Microbiological Diagnostic Performance of Metagenomic Next-generation Sequencing When Applied to Clinical Practic [J]. Clin Infect Dis，2018， 67：S231-S240.
2023, Vol. 20 
京公网安备 11010502046598号